Volumetric Evaluation of Substantia Nigra in Major Depressive Disorder Using Atlas-Based Method
Open Access
- 16 May 2024
- journal article
- research article
- Published by LookUs Bilisim A.S. in Medical Records
- Vol. 6 (2) , 190-195
Abstract
Aim: The substantia nigra pars compacta (SNc), a vital part of the brain that produces dopamine, is being closely studied due to its potential role in the monoamine hypothesis, which aims to explain the causes of Major Depressive Disorder (MDD). Dopamine, a chemical messenger in the brain, is linked to the monoamine hypothesis, suggesting that imbalances in these chemicals may contribute to MDD. This study aimed to calculate volumetric changes in the substantia nigra (SN), using brain magnetic resonance imaging (MRI) in individuals diagnosed with MDD. Material and Method: Sixty-six participants, comprising 33 individuals diagnosed with MDD (mean age=44.30±13.98 years) and 33 healthy individuals (mean age=46.27±14.94 years), were recruited from the university hospital psychiatry outpatient clinic. In the MDD group, there were 15 male participants (45%) and 18 female participants (55%). The healthy control group consisted of 28 males (84.8%) and 5 females (16.2%). Potential confounding factors, such as underlying chronic diseases, were ruled out by the clinician through a thorough examination of the patient's medical history, ensuring the study outcomes were not influenced. Three-dimensional brain MRI scans were conducted using a 1.5 Tesla MRI scanner. Volumes of the SN and midbrain were automatically computed using MRIStudio, an atlas-based image analysis program. Results: Statistically significant higher volumes were observed in the right SN in the MDD group compared to controls (0.146±0.045 cm³ vs. 0.122±0.035 cm³, p=0.02, pKeywords
This publication has 37 references indexed in Scilit:
- Protective mechanism of Syringic acid in an experimental model of Parkinson’s diseaseMetabolic Brain Disease, 2021
- The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depressionMolecular Biology Reports, 2019
- Monoaminergic system and depressionCell and tissue research, 2019
- Longitudinal brain volume changes in major depressive disorderJournal of Neural Transmission, 2018
- Neuropathological changes in the substantia nigra in schizophrenia but not depressionEuropean Archives of Psychiatry and Clinical Neuroscience, 2013
- 3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson’s diseaseNeuroradiology, 2013
- Substantia Nigra Volume Loss Before Basal Forebrain Degeneration in Early Parkinson DiseaseJAMA Neurology, 2013
- T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's diseaseMovement Disorders, 2011
- Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluencyEuropean Archives of Psychiatry and Clinical Neuroscience, 2008
- The Epidemiology of Major Depressive DisorderJAMA, 2003